Verily’s Post

Selenge Province has started the implementation of the updated plan for its AI-based “Tuberculosis-free Selenge” program. Early detection and diagnosis examinations and diagnostics were organized in Altanbulag this month. At the 16th session of the People’s Representatives Meeting of the province, the updated plan of the “Tuberculosis-free Selenge” event was approved. The new AI technology is an option on the CMDR portable digital radiography system from MinXray. With the help of AI, the CMDR digital X-ray system can identify 10 types of lung diseases such as atelectasis, lung calcification, pulmonary infiltrates, lung scarring, pleural mesenteric changes, pleurisy, pleural gas, abdominal nodules and heart enlargement, and gastrointestinal perforation. Selenge Province is the first to introduce a portable digital x-ray machine in their local area. The Health Department of Selenge province plans to organize early detection examinations and diagnostics in 23 communities in the future. #MinXray #PortableXray #StopTB #DigitalRadiography #Mongolia

I started working at Powerful Medical in August, and let me tell you, it’s been quite a ride! 🚀 Working with skilled and hard-working people has made the last four months so eventful. At first, I was unsure about the fast pace, but now I wouldn’t trade this experience for anything. Our team’s determination and passion are remarkable, and we’re achieving things that usually take much longer in other companies. And the best part, our product can literally save people’s lives. ✨ If you didn’t already know, heart attacks are a major global issue, with 30% of specific cases initially misdiagnosed, leading to delayed treatment and sometimes even death. This is where our powerful product comes in. The #QueenOfHearts 👑 is an innovative AI tool which can detect OMI (Occlusion Myocardial Infarction) more accurately and much earlier compared to current methods. It is good at spotting tricky, subtle ECG patterns that even the best cardiologists might not see. A game-changer in healthcare industry and hearth diagnostics. 🫀 I’m extremely grateful to be part of this journey. 💙 You can learn about what we do and the Queen of Hearts here: https://lnkd.in/gDj6XdAG

🚀 happy to share our latest publication in Vascular! Our review article, "How to improve epidemiological trustworthiness concerning abdominal aortic aneurysms," addresses the challenges of current AAA data and proposes solutions for better diagnosis, prognostication, and management. We suggest shifting from absolute aortic-size thresholds to relative aortic indices and emphasize the need for standardizing aortometry with a focus on simplicity and accuracy. Integrating clinical data with advanced imaging and AI-powered tools can significantly enhance patient care. Kudos to Fabio Zecca for his exceptional contribution. https://lnkd.in/g2gPR9YZ #VascularResearch #HealthcareInnovation #PatientCare

I‘m excited to share that our latest article on #keratoconus detection is now published in Cornea. We’ve revealed that 46% of keratoconus patients’ eyes which are seemingly normal on Scheimpflug tomography, show early ectatic changes when assessed with anterior segment OCT. Discover more about how our findings could advance early ectasia detection and patient care! 👀 Read the full study in the July issue of Cornea: https://lnkd.in/ejFQhN8s #Ophthalmology #EctasiaDetection

GE HealthCare is making significant strides in healthcare with a $44 million contract signed with BARDA. They're developing cutting-edge AI-augmented ultrasound technology to aid clinicians in diagnosing and treating traumatic injuries, including lung pathologies. This innovation promises to improve patient care, enhance resource management, and boost preparedness for mass casualty events. It's a game-changer that will undoubtedly save lives. Read more about this groundbreaking development https://lnkd.in/eFnetJeJ 📰 Follow Practical Patient Care to receive the latest healthcare news daily that is important to you and to subscribe to our weekly newsletter #practicalpatientcare #GEHealthCare #AI #UltrasoundTechnology

🌟 𝘽𝙞𝙜 𝙍𝙚𝙫𝙚𝙖𝙡 𝙖𝙩 𝙩𝙝𝙚 Radical Health Festival Helsinki! 🌟 🔎𝘎𝘶𝘦𝘴𝘴 𝘸𝘩𝘰’𝘴 𝘫𝘰𝘪𝘯𝘪𝘯𝘨 𝘵𝘩𝘦 𝘖𝘶𝘭𝘶𝘏𝘦𝘢𝘭𝘵𝘩 𝘴𝘵𝘢𝘯𝘥 𝘪𝘯 𝘏𝘦𝘭𝘴𝘪𝘯𝘬𝘪? 𝘐𝘵’𝘴 𝘯𝘰𝘯𝘦 𝘰𝘵𝘩𝘦𝘳 𝘵𝘩𝘢𝘯 Cerenion Oy 🚀 🎊As an expert in brain monitoring technology, they are excited to showcase their groundbreaking C-Trend® system. It’s not just about monitoring; it’s about understanding and improving patient care. 🧠💡 📣Key Features of Cerenion C-Trend®:  ✅𝗙𝗮𝘀𝘁 𝗥𝗲𝘀𝘂𝗹𝘁𝘀: Within minutes, C-Trend® provides a reliable view into the brain.🔮  ✅𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗜𝗻𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀: It’s used for monitoring brain function in comatose cardiac arrest survivors, detecting epileptic seizure activity, and assessing brain hypoxia.🧠  ✅𝗖𝗘-𝗠𝗮𝗿𝗸𝗲𝗱 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲: C-Trend® is a CE-marked Class IIb medical device, meeting rigorous quality standards.🌈 🔗Learn more:https://lnkd.in/dVTugnMP Jukka Kortelainen Eero Väyrynen #Cerenion #CTrend #BrainMonitoring #HealthTech #RadicalHealthFestival #Innovation #Healthcare

✨ Transforming Cardiac Care: Boston Scientific's FARAPULSE, Inc. System ✨ Boston Scientific, a trailblazer in medical technology, has unveiled compelling clinical data from a head-to-head trial, shedding light on the remarkable potential of its pulsed field ablation approach in managing irregular heartbeats. The results speak volumes. 💓 The Farapulse system stands shoulder-to-shoulder with traditional ablation methods in terms of effectiveness while offering a distinct advantage - a substantial reduction in complications. This innovation is a beacon of hope for those affected by heart arrhythmias, and it reaffirms Boston Scientific's commitment to advancing patient care. 🏥🔬 #medicalinnovation #cardiaccare #Farapulse #hearthealth #medtech #innovation #clinicaltrials #bostonscientific

We would like to announce our collaboration with MassMEDIC once again with our upcoming Medical Device Manufacturing and R&D Summit 2024! We are thankful for this great opportunity and hope that this strategic partnership lasts for a long time. MassMEDIC presents: What are you waiting for? Early bird rates are now LIVE for MassMEDIC ’s Annual Medtech Impact Symposium - and are only good through Feb. 2! Bringing together diverse industry stakeholders to discuss the impact medical technology has on improving healthcare outcomes, the Medtech Impact Symposium is the premier medtech event in New England. Focusing on the technologies poised to shape the medtech industry, the day-long conversation will encompass topics such as the use of data and AI to improve medical technology and personalize medicine. They will also take a deep dive into the impact of medical technology on care within four distinct areas: Maternal Health, Cardiac Health, Diabetes, and Musculoskeletal Health. Register now to reserve your seat. And, save $100 through Feb. 2 with early bird rates. https://lnkd.in/evkNWaTi #medtech #impact #symposium #heartofhealthtech #innovation #maternalhealth #cardiachealth #diabetes #musculoskeletalhealth #AI #personalizemedicine #earlybird #savings

We're thrilled to be part of #HRS2024 in Boston! Join us to explore how #Medicalgorithmics is enhancing patient care standards. Our FDA-approved software and devices enable healthcare providers in the US to diagnose and manage patients with arrhythmias with exceptional efficacy. Jarosław (Jarek) Jerzakowski and Przemek Tadla will be present at the event, ready to discuss our innovative cardiac diagnostic solutions. Here's what we're bringing to the table: 🧠 Our AI algorithms and diagnostic platform are standalone wonders, seamlessly integrating with your existing systems. 💓 While we offer #PocketECG heart monitoring devices, our diagnostic platform can sync with data from almost any device. 🚀 And don't miss out on our subsidiary, Kardiolytics Inc, which is developing #VCAST technology, leveraging AI for non-invasive diagnosis of coronary artery disease using heart CT data. For more information, visit www.medicalgorithmics.com Looking forward to connecting with you at #HRS2024 in Boston! #MedTech #MedicalDevices #HealthcareInnovations #MedicalTechnology #CardiologyProfessionals #Cardiology #RemoteMonitoring #AI

Cardiovascular disease is the leading cause of death globally, with the number of diagnoses expected to rise as people live longer and the population increases. Early detection of heart disease is critical to improving patient outcomes, but providing rapid assessments at the point of care can be difficult as health systems and facilities are facing challenges like staffing shortages, an increasing number of patients, and resource constraints.     Today, ahead of the American College of Cardiology Annual Scientific Session, GE HealthCare has launched Vscan Air SL with Caption AI to help address these challenges.    This latest innovation provides clinicians with real-time, step-by-step guidance to capture diagnostic-quality images at the point of care and help inform clinical decisions across cardiac settings – even for qualified healthcare professionals with minimal ultrasound training.     I am excited to take Vscan Air SL a step further with this Caption AI technology integration and look forward to seeing how AI can positively impact and accelerate our ultrasound technologies.     Learn more: https://lnkd.in/d-EAAUzp   #ACC24 #GEHealthCare #VscanAirSL #AI #Ultrasound #FutureofHealthcare